LONG COVID19

Clinical trials for LONG COVID19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID19 trials appear

Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 6

New drug targets immune chaos in long COVID POTS patients

Knowledge-focused Recruiting now

This study looks at why some people with Long COVID develop POTS, a condition causing rapid heartbeat and fatigue. Researchers will test a drug called 2-HOBA to see if it can calm an overactive immune system. About 50 adults with Long COVID and POTS will take either the drug or a…

Matched conditions: LONG COVID19

Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused

Last updated May 15, 2026 11:56 UTC

LONG COVID19

Get alerted when new LONG COVID19 trials appear

New drug targets immune chaos in long COVID POTS patients